<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>BAYTRIL- enrofloxacinÂ injection, solutionÂ </strong><br>Bayer HealthCare LLC Animal Health Division<br></p></div>
<h1>
<span class="Bold">Baytril<span class="Sup">Â®</span> 100 </span><br><span class="Bold">(enrofloxacin)</span>
</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_8f0d4bed-0046-4929-b21e-8c1b4d53c2fa"></a><a name="section-1"></a><p></p>
<div class="Figure">
<a name="id-2050294403"></a><img alt="Animals image" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=401d2b8c-872b-4ffc-b100-22663b0f6bbb&amp;name=image-01.jpg">
</div>
<p class="First"><span class="Bold">100 mg/mL Antimicrobial</span><br><span class="Bold">Injectable Solution</span></p>
<p>For Subcutaneous Use In Beef Cattle And Non-Lactating Dairy Cattle<br>For Intramuscular Or Subcutaneous Use In Swine<br>Not For Use In Female Dairy Cattle 20 Months Of Age Or Older<br>Or In Calves To Be Processed For Veal</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_55c7dacf-4a66-4ce9-8681-0edd637a9e10"></a><a name="section-2"></a><p></p>
<h1>CAUTION:</h1>
<p class="First">Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian.<br>Federal (U.S.A.) law prohibits the extra-label use of this drug in food-producing animals.</p>
<p>To assure responsible antimicrobial drug use, enrofloxacin should only be used as a second-line drug for colibacillosis in swine following consideration of other therapeutic options.</p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_9e55d21f-eef3-4499-9f1d-416dcad61bd0"></a><a name="section-3"></a><p></p>
<h1>PRODUCT DESCRIPTION:</h1>
<p class="First">Baytril<span class="Sup">Â®</span> 100 is a sterile, ready-to-use injectable antimicrobial solution that contains enrofloxacin, a broad-spectrum fluoroquinolone antimicrobial agent.</p>
<p>Each mL of Baytril<span class="Sup">Â®</span> 100 contains 100 mg of enrofloxacin. Excipients are L-arginine base 200 mg, n-butyl alcohol 30 mg, benzyl alcohol (as a preservative) 20 mg and water for injection q.s.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_e0f2194a-edf2-47d3-bf8a-dbb0d93fd447"></a><a name="section-3.1"></a><p></p>
<h2>CHEMICAL NOMENCLATURE AND STRUCTURE:</h2>
<p class="First">1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid.</p>
<div class="Figure">
<a name="id255"></a><img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=401d2b8c-872b-4ffc-b100-22663b0f6bbb&amp;name=a181133d-4163-4674-812c-77d19f4d6837-01.jpg">
</div>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="i4i_indications_id_cea53a3f-8fdb-419b-ba62-63b2024143fe"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS:</h1>
<p class="First"><span class="Bold">Cattle - Single-Dose Therapy: </span>Baytril<span class="Sup">Â®</span> 100 is indicated for the treatment of bovine respiratory disease (BRD) associated with <span class="Italics">Mannheimia haemolytica, Pasteurella multocida, Histophilus somni</span> and <span class="Italics">Mycoplasma bovis </span>in beef and non-lactating dairy cattle; and for the control of BRD in beef and non-lactating dairy cattle at high risk of developing BRD associated with <span class="Italics">M. haemolytica, P. multocida, H. somni </span>and <span class="Italics">M. bovis.</span></p>
<p><span class="Bold">Cattle - Multiple-Day Therapy: </span>Baytril<span class="Sup">Â®</span> 100 is indicated for the treatment of bovine respiratory disease (BRD) associated with <span class="Italics">Mannheimia haemolytica, Pasteurella multocida </span>and <span class="Italics">Histophilus somni </span>in beef and non-lactating dairy cattle.</p>
<p><span class="Bold">Swine: </span>Baytril<span class="Sup">Â®</span> 100 is indicated for the treatment and control of swine respiratory disease (SRD) associated with <span class="Italics">Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis, Streptococcus suis, Bordetella bronchiseptica </span>and <span class="Italics">Mycoplasma hyopneumoniae.</span> Baytril<span class="Sup">Â®</span> 100 is indicated for the control of colibacillosis in groups or pens of weaned pigs where colibacillosis associated with <span class="Italics">Escherichia coli </span>has been diagnosed.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_dosage_admin_id_1f12d44d-f1ee-4064-af08-5d96c76844b9"></a><a name="section-5"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION:</h1>
<p class="First">Baytril<span class="Sup">Â®</span> 100 provides flexible dosages and durations of therapy.</p>
<p>Baytril<span class="Sup">Â®</span> 100 may be administered as a single dose for one day for treatment and control of BRD (cattle), for treatment and control of SRD or for control of colibacillosis (swine), or for multiple days for BRD treatment (cattle). Selection of the appropriate dose and duration of therapy for BRD treatment in cattle should be based on an assessment of the severity of the disease, pathogen susceptibility and clinical response.</p>
<p>500 mL--Do not enter the vial with a needle more than 30 times or enter the vial with a dosage deliver device more than 4 times. Any product remaining after these maximum number of entries should be discarded.</p>
<p><span class="Bold">Cattle:</span></p>
<p><span class="Bold">Single-Dose Therapy (BRD Treatment):</span> Administer, by subcutaneous injection, a single dose of 7.5-12.5 mg/kg of body weight (3.4-5.7 mL/100 lb).</p>
<p><span class="Bold">Multiple-Day Therapy (BRD Treatment): </span>Administer daily, a subcutaneous dose of 2.5-5 mg/kg of body weight (1.1-2.3 mL/100 lb). Treatment should be repeated at 24-hour intervals for three days. Additional treatments may be given on Days 4 and 5 to animals that have shown clinical improvement but not total recovery.</p>
<p><span class="Bold">Single-Dose Therapy (BRD Control): </span>Administer, by a subcutaneous injection, a single dose of 7.5 mg/kg of body weight (3.4 mL/100 lb). Examples of conditions that may contribute to calves being at high risk of developing BRD include, but are not limited to, the following:</p>
<dl>
<dt>â€¢</dt>
<dd>Transportation with animals from two or more farm origins.</dd>
<dt>â€¢</dt>
<dd>An extended transport time with few to no rest stops.</dd>
<dt>â€¢</dt>
<dd>An environmental temperature change of â‰¥30Â°F during transportation.</dd>
<dt>â€¢</dt>
<dd>A â‰¥30Â°F range in temperature fluctuation within a 24-hour period.</dd>
<dt>â€¢</dt>
<dd>Exposure to wet or <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">cold</span> weather conditions.</dd>
<dt>â€¢</dt>
<dd>Excessive shrink (more than would be expected with a normal load of cattle).</dd>
<dt>â€¢</dt>
<dd>Stressful arrival processing procedures (e.g., castration or dehorning).</dd>
<dt>â€¢</dt>
<dd>Exposure within the prior 72 hours to animals showing clinical signs of BRD.</dd>
</dl>
<p>Administered dose volume should not exceed 20 mL per injection site.</p>
<table width="100%">
<caption><span>Table 1 â€“ Baytril<span class="Sup">Â®</span> 100 Dose and Treatment Schedule for Cattle<a name="footnote-reference-1" href="#footnote-1" class="Sup">*</a></span></caption>
<col width="25%">
<col width="25%">
<col width="25%">
<col width="25%">
<tfoot><tr><td colspan="4" align="left"><dl class="Footnote">
<dt><a name="footnote-1" href="#footnote-reference-1">*</a></dt>
<dd>Dose volumes have been rounded to the nearest 0.5 mL within the dose range.</dd>
</dl></td></tr></tfoot>
<tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Rrule Toprule" align="center" rowspan="2" valign="middle"><p class="First">Weight<br>(lb)</p></td>
<td class="Botrule Rrule Toprule" align="center" colspan="2" valign="middle"><p class="First">Treatment</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="middle"><p class="First">Control</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">Single-Dose Therapy<br>7.5 - 12.5 mg/kg<br>Dose Volume (mL)</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">Multiple-Day Therapy<br>2.5 - 5.0 mg/kg<br>Dose Volume (mL)</p></td>
<td class="Botrule Lrule Rrule" align="center" valign="middle"><p class="First">Single-Dose Therapy<br>7.5 mg/kg<br>Dose Volume (mL)</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">100</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">3.5 - 5.5</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">1.5 - 2.0</p></td>
<td class="Botrule Lrule Rrule" align="center" valign="middle"><p class="First">3.5</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">200</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">7.0 - 11.0</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">2.5 - 4.5</p></td>
<td class="Botrule Lrule Rrule" align="center" valign="middle"><p class="First">7.0</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">300</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">10.5 - 17.0</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">3.5 - 6.5</p></td>
<td class="Botrule Lrule Rrule" align="center" valign="middle"><p class="First">10.5</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">400</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">14.0 - 22.5</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">4.5 - 9.0</p></td>
<td class="Botrule Lrule Rrule" align="center" valign="middle"><p class="First">14.0</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">500</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">17.0 - 28.5</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">5.5 - 11.5</p></td>
<td class="Botrule Lrule Rrule" align="center" valign="middle"><p class="First">17.0</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">600</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">20.5 - 34.0</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">7.0 - 13.5</p></td>
<td class="Botrule Lrule Rrule" align="center" valign="middle"><p class="First">20.5</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">700</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">24.0 - 39.5</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">8.0 - 16.0</p></td>
<td class="Botrule Lrule Rrule" align="center" valign="middle"><p class="First">24.0</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">800</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">27.5 - 45.5</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">9.0 - 18.0</p></td>
<td class="Botrule Lrule Rrule" align="center" valign="middle"><p class="First">27.5</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">900</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">31.0 - 51.0</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">10.0 - 20.5</p></td>
<td class="Botrule Lrule Rrule" align="center" valign="middle"><p class="First">31.0</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">1000</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">34.0 - 57.0</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">11.0 - 23.0</p></td>
<td class="Botrule Lrule Rrule" align="center" valign="middle"><p class="First">34.0</p></td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">1100</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">37.5 - 62.5</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">12.5 - 25.0</p></td>
<td class="Botrule Rrule" align="center" valign="middle"><p class="First">37.5</p></td>
</tr>
</tbody>
</table>
<p><span class="Bold">Swine:</span></p>
<p>Administer, either by intramuscular or subcutaneous (behind the ear) injection, a single dose of 7.5 mg/kg of body weight (3.4 mL/100 lb). Administered dose volume should not exceed 5 mL per injection site.</p>
<p>For the control of colibacillosis, administration should be initiated within the first 60 days post-weaning when clinical signs are present in at least 2% of the animals in the group. If no improvement is noted within 48 hours, the diagnosis should be reevaluated.</p>
<table width="100%">
<caption><span>Table 2 â€“ Baytril<span class="Sup">Â®</span> 100 Dose Schedule for Swine</span></caption>
<col width="50%">
<col width="50%">
<tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"><p class="First">Weight (lb)</p></td>
<td class="Botrule Rrule Toprule" align="center" valign="top"><p class="First">Dose Volume (mL)</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">15</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">0.5</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">30</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">1.0</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">50</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">1.7</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">100</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">3.4</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">150</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">5.1</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">200</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">6.8</p></td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">250</p></td>
<td class="Botrule Rrule" align="center" valign="top"><p class="First">8.5</p></td>
</tr>
</tbody>
</table>
<p><span class="Bold">Dilution of Baytril</span><span class="Sup">Â®</span><span class="Bold"> 100: </span>Baytril<span class="Sup">Â®</span> 100 may be diluted with sterile water prior to injection. The diluted product should be used within 24 hours. Store diluted solution in amber glass bottles between 4-40Â°C (36-104Â°F).</p>
<table width="100%">
<caption><span>Table 3 â€“ Dilution Schedule<a name="footnote-reference-2" href="#footnote-2" class="Sup">*</a></span></caption>
<col width="25%">
<col width="25%">
<col width="25%">
<col width="25%">
<tfoot><tr><td colspan="4" align="left"><dl class="Footnote">
<dt><a name="footnote-2" href="#footnote-reference-2">*</a></dt>
<dd>For 1 mL dose volume from diluted solution</dd>
</dl></td></tr></tfoot>
<tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"><p class="First">Swine Weight</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"><p class="First">mL of Baytril<span class="Sup">Â®</span> 100</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"><p class="First">mL of sterile water</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"><p class="First">Number of doses</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">10 lb</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"><p class="First">34 mL</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"><p class="First">66 mL</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"><p class="First">100</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">15 lb</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"><p class="First">51 mL</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"><p class="First">49 mL</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"><p class="First">100</p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="top"><p class="First">20 lb</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"><p class="First">68 mL</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"><p class="First">32 mL</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"><p class="First">100</p></td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"><p class="First">25 lb</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"><p class="First">85 mL</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"><p class="First">15 mL</p></td>
<td class="Botrule Lrule Rrule Toprule" align="center" valign="top"><p class="First">100</p></td>
</tr>
</tbody>
</table>
</div>
<div class="Section" data-sectionCode="53412-3">
<a name="i4i_residue_warning_id_5dced69d-b340-4024-a398-508589f881d6"></a><a name="section-6"></a><p></p>
<h1>RESIDUE WARNINGS:</h1>
<p class="First"><span class="Bold">Cattle</span>: Animals intended for human consumption must not be slaughtered within 28 days from the last treatment. This product is not approved for female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.</p>
<p><span class="Bold">Swine</span>: Animals intended for human consumption must not be slaughtered within 5 days of receiving a single-injection dose.</p>
</div>
<div class="Section" data-sectionCode="54433-8">
<a name="i4i_user_safety_id_00e798ef-240f-444c-9250-90319d12dc8d"></a><a name="section-7"></a><p></p>
<h1>HUMAN WARNINGS:</h1>
<p class="First"><span class="Bold">Not for use in humans. Keep out of reach of children.</span> Avoid contact with eyes. In case of contact, immediately flush eyes with copious amounts of water for 15 minutes. In case of dermal contact, wash skin with soap and water. Consult a physician if irritation persists following ocular or dermal exposures. Individuals with a history of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to quinolones should avoid this product. In humans, there is a risk of user photosensitization within a few hours after excessive exposure to quinolones. If excessive accidental exposure occurs, avoid direct sunlight. For customer service or to obtain product information, including a Safety Data Sheet, call 1-800-633-3796. For medical emergencies or to report adverse reactions, call 1-800-422-9874.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="i4i_precautions_id_a4ce5b99-61b2-472d-9c7e-d32d2a6b9efc"></a><a name="section-8"></a><p></p>
<h1>PRECAUTIONS:</h1>
<p class="First">The effects of enrofloxacin on cattle or swine reproductive performance, pregnancy and lactation have not been adequately determined.</p>
<p>The long-term effects on articular joint cartilage have not been determined in pigs above market weight.</p>
<p>Subcutaneous injection in cattle and swine, or intramuscular injection in swine, can cause a transient local tissue reaction that may result in trim loss of edible tissue at slaughter.</p>
<p>Baytril<span class="Sup">Â®</span> 100 contains different excipients than other Baytril<span class="Sup">Â®</span> products. The safety and efficacy of this formulation in species other than cattle and swine have not been determined.</p>
<p>Quinolone-class drugs should be used with caution in animals with known or suspected Central Nervous System (CNS) disorders. In such animals, quinolones have, in rare instances, been associated with CNS stimulation which may lead to <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsive seizures</span>. Quinolone-class drugs have been shown to produce erosions of cartilage of weight-bearing joints and other signs of <span class="product-label-link" type="condition" conceptid="73553" conceptname="Arthropathy">arthropathy</span> in immature animals of various species. See Animal Safety section for additional information.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="i4i_adverse_effects_id_365eccb5-16c7-479b-bf66-a583aec2361d"></a><a name="section-9"></a><p></p>
<h1>ADVERSE REACTIONS: </h1>
<p class="First">No adverse reactions were observed during clinical trials.</p>
<p>For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or online at http://www.fda.gov/AnimalVeterinary/SafetyHealth.</p>
</div>
<div class="Section" data-sectionCode="49489-8">
<a name="i4i_microbiology_id_3be82184-63f1-4198-9182-543ee2faaf63"></a><a name="section-10"></a><p></p>
<h1>MICROBIOLOGY: </h1>
<p class="First">Enrofloxacin is bactericidal and exerts its antibacterial effect by inhibiting bacterial DNA gyrase (a type II topoisomerase) thereby preventing DNA supercoiling and replication which leads to <span class="product-label-link" type="condition" conceptid="4034461" conceptname="Cytolysis">cell death</span>.<span class="Sup">1</span> Enrofloxacin is active against Gram-negative and Gram-positive bacteria. </p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_c47bee9b-5801-49bf-88fe-05f068ec6bc8"></a><a name="section-11"></a><p></p>
<h1>EFFECTIVENESS:</h1>
<p class="First"><span class="Bold">Cattle</span>: A total of 845 calves with naturally-occurring BRD were treated with Baytril<span class="Sup">Â®</span> 100 in eight field trials located in five cattle-feeding states. Response to treatment was compared to non-treated controls. Single-dose and multiple-day therapy regimens were evaluated. BRD and mortality were significantly reduced in enrofloxacin-treated calves. No adverse reactions were reported in treated animals.</p>
<p>The effectiveness of Baytril<span class="Sup">Â®</span> 100 for the control of respiratory disease in cattle at high risk of developing BRD was evaluated in a six-location study in the U.S. and Canada. A total of 1,150 crossbred beef calves at high risk of developing BRD were enrolled in the study. Baytril<span class="Sup">Â®</span> 100 (7.5 mg/kg BW) or an equivalent volume of sterile saline was administered as a single subcutaneous injection within two days after arrival. Cattle were observed daily for clinical signs of BRD and were evaluated for success on Day 14 post-treatment. Treatment success in the Baytril<span class="Sup">Â®</span> 100 group (497/573, 87.83%) was significantly higher (P = 0.0013) than success in the saline control group (455/571, 80.92%). In addition, there were more treatment successes (n = 13) than failures (n = 3) in the group of animals positive for <span class="Italics">M. bovis </span>on Day 0 that were treated with Baytril<span class="Sup">Â®</span> 100. No product-related adverse reactions were reported.</p>
<p><span class="Bold">Swine</span>: A total of 590 pigs were treated with Baytril<span class="Sup">Â®</span>100 or saline in two separate natural <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> SRD field trials. For the treatment of SRD, the success rate of enrofloxacin-treated pigs that were defined as â€œsick and febrileâ€? (increased <span class="product-label-link" type="condition" conceptid="4313591" conceptname="Respiratory rate">respiratory rate</span>, labored or dyspneic breathing, depressed attitude and a rectal temperature â‰¥ 104Â°F) was statistically significantly greater than the success rate of saline-treated â€œsick and febrileâ€? pigs. For the control of SRD, mean rectal temperature, mortality (one trial) and morbidity were statistically significantly lower for enrofloxacin-treated pigs in pens containing a percentage of â€œsick and febrileâ€? pigs compared to saline-treated pigs.</p>
<p>The effectiveness of Baytril<span class="Sup">Â®</span> 100 administered as a single SC dose of 7.5 mg/kg BW for the treatment and control of SRD associated with <span class="Italics">M. hyopneumoniae</span> was demonstrated using an induced <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> model study and three single-site natural <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> field studies. In the model study, 72 healthy pigs were challenged with a representative <span class="Italics">M. hyopneumoniae</span> isolate and treated with Baytril<span class="Sup">Â®</span> 100 or saline. A statistically significant (P &lt; 0.0001) decrease in the mean total lung lesion score was observed in the Baytril<span class="Sup">Â®</span> 100-treated group (4%) compared with the saline-treated group (27%) at 10 days post-treatment. In two field studies evaluating effectiveness for treatment of SRD, a total of 300 pigs with clinical signs of SRD (moderate <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>, moderately increased <span class="product-label-link" type="condition" conceptid="4313591" conceptname="Respiratory rate">respiratory rate</span>, and a rectal temperature of â‰¥ 104Â°F) were enrolled and treated with Baytril<span class="Sup">Â®</span> 100 or saline. At 7 days post-treatment, the cure rate was statistically significantly higher at each site (P &lt; 0.0001) in the Baytril<span class="Sup">Â®</span> 100-treated groups (61.3% and 92%) compared with the saline-treated groups (26.7% and 33.3%). In one field study evaluating effectiveness for control of SRD, a group of 400 pigs in which &gt; 15% had clinical signs of SRD (moderate <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> score, moderately increased <span class="product-label-link" type="condition" conceptid="4313591" conceptname="Respiratory rate">respiratory rate</span>, and a rectal temperature of â‰¥  104Â°F) was enrolled and treated with Baytril<span class="Sup">Â®</span> 100 or saline. At 7 days post-treatment, the cure rate was statistically significantly higher (P &lt; 0.0002) in the Baytril<span class="Sup">Â®</span> 100-treated group (70.0%) compared with the saline-treated group (48.5%). In addition to <span class="Italics">M.Â hyopneumoniae</span>, <span class="Italics">B.Â bronchiseptica</span> was also isolated in sufficient numbers from these field studies to be included in the SRD treatment and control indications.</p>
<p>The effectiveness of Baytril<span class="Sup">Â®</span> 100 for the control of colibacillosis associated with <span class="Italics">E. coli </span>was evaluated in a multi-site natural <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> field study. At each site, when at least 5% of the pigs were defined as â€œclinically affectedâ€? (presence of <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> and either <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> or gauntness), all pigs were administered Baytril<span class="Sup">Â®</span> 100 as a single IM dose of 7.5 mg/kg BW or an equivalent dose volume of saline. At 7 days post-treatment, the success rate was statistically significantly higher (P = 0.0350) in the Baytril<span class="Sup">Â®</span> 100-treated group (61.5%) compared with the saline-treated group (44.7%).</p>
<p>The effectiveness of Baytril<span class="Sup">Â®</span> 100 administered as a single IM dose of 7.5 mg/kg BW for the treatment and control of SRD or as a single SC dose of 7.5 mg/kg BW for the control of colibacillosis was confirmed by demonstrating comparable serum enrofloxacin concentrations following IM or SC injection into the neck of healthy male and female pigs.</p>
</div>
<div class="Section" data-sectionCode="34091-9">
<a name="i4i_animal_pharmacology_id_10f10d3f-a2cf-45f1-890e-0927540c0b43"></a><a name="section-12"></a><p></p>
<h1>TOXICOLOGY: </h1>
<p class="First">The oral LD50 for laboratory rats was greater than 5000 mg/kg of body weight. Ninety-day feeding studies in dogs and rats revealed no observable adverse effects at treatment rates of 3 and 40 mg/kg respectively. Chronic studies in rats and mice revealed no observable adverse effects at 5.3 and 323 mg/kg respectively. There was no evidence of carcinogenic effect in laboratory animal models. A two-generation rat reproduction study revealed no effect with 10 mg/kg treatments. No teratogenic effects were observed in rabbits at doses of 25 mg/kg or in rats at 50 mg/kg.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_5dd95082-fd9c-4dcd-bee7-b68dbad2f9bb"></a><a name="section-13"></a><p></p>
<h1>ANIMAL SAFETY: </h1>
<p class="First"><span class="Bold">Cattle</span>: Safety studies were conducted in feeder calves using single doses of 5, 15 and 25 mg/kg for 15 consecutive days and 50 mg/kg for 5 consecutive days. No clinical signs of toxicity were observed when a dose of 5 mg/kg was administered for 15 days. Clinical signs of <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>, <span class="product-label-link" type="condition" conceptid="441417" conceptname="Incoordination">incoordination</span> and <span class="product-label-link" type="condition" conceptid="4189159" conceptname="Muscle fibrillation">muscle fasciculation</span> were observed in calves when doses of 15 or 25 mg/kg were administered for 10 to 15 days. Clinical signs of <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>, inappetance and <span class="product-label-link" type="condition" conceptid="441417" conceptname="Incoordination">incoordination</span> were observed when a dose of 50 mg/kg was administered for 3 days. No drug-related abnormalities in clinical pathology parameters were identified. No articular cartilage lesions were observed after examination of stifle joints from animals administered 25 mg/kg for 15 days. </p>
<p>A safety study was conducted in 23-day-old calves using doses of 5, 15 and 25 mg/kg for 15 consecutive days. No clinical signs of toxicity or changes in clinical pathology parameters were observed. No articular cartilage lesions were observed in the stifle joints at any dose level at 2 days and 9 days following 15 days of drug administration.</p>
<p>An injection site study conducted in feeder calves demonstrated that the formulation may induce a transient reaction in the subcutaneous tissue and underlying muscle. No painful responses to administration were observed.</p>
<p><span class="Bold">Swine</span>: <span class="Bold">Subcutaneous Safety:</span>Â A safety study was conducted in 32 pigs weighing approximately 57 kg (125 lb) using single doses of 5, 15, or 25 mg/kg daily for 15 consecutive days. Incidental lameness of short duration was observed in all groups, including the saline-treated controls. <span class="product-label-link" type="condition" conceptid="4060220" conceptname="Stiff neck">Musculoskeletal stiffness</span> was observed following the 15 and 25 mg/kg treatments with clinical signs appearing during the second week of treatment. Clinical signs of lameness improved after treatment ceased and most animals were clinically normal at necropsy.</p>
<p>A second study was conducted in two pigs weighing approximately 23 kg (50 lb), treated with 50 mg/kg for 5 consecutive days. There were no clinical signs of toxicity or pathological changes. </p>
<p>An injection site study conducted in pigs demonstrated that the formulation may induce a transient reaction in the subcutaneous tissue. No painful responses to administration were observed.</p>
<p><span class="Bold">Intramuscular Safety: </span>A safety study was conducted in 48 weaned, 20- to 22-day-old pigs. Pigs were administered Baytril<span class="Sup">Â®</span> 100, at 7.5, 22.5 and 37.5 mg/kg BW by IM injection into the neck once weekly for 3 consecutive weeks. All pigs remained clinically normal throughout the study. Transient decreases in feed and water consumption were observed after each treatment. Mild, transient, post-treatment <span class="product-label-link" type="condition" conceptid="4319319" conceptname="Injection site edema">injection site swellings</span> were observed in pigs receiving the 37.5 mg/kg BW dose. <span class="product-label-link" type="condition" conceptid="4319318" conceptname="Injection site inflammation">Injection site inflammation</span> was found on post-mortem examination in all enrofloxacin-treated groups.</p>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="i4i_storage_id_9ec65f6b-c5ed-410b-80b7-f0bfca0d212c"></a><a name="section-14"></a><p></p>
<h1>STORAGE CONDITIONS: </h1>
<p class="First">Protect from direct sunlight. Do not refrigerate or freeze. Store at 20-30<span class="Sup">o</span>C (68-86<span class="Sup">o</span>F), excursions permitted up to 40<span class="Sup">o</span>C (104<span class="Sup">o</span>F). Precipitation may occur due to <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">cold</span> temperature. To redissolve, warm and then shake the vial.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="i4i_how_supplied_id_49496fe3-1213-4475-9694-a65424588583"></a><a name="section-15"></a><p></p>
<h1>HOW SUPPLIED:</h1>
<p class="First">Baytril<span class="Sup">Â®</span> 100:</p>
<p>Code: 08711170-023699Â Â Â Â Â Â Â Â Â Â 100 mg/mLÂ Â Â Â Â Â Â Â Â Â 100 mL Bottle<br>Code: 08711278-032199Â Â Â Â Â Â Â Â Â Â 100 mg/mLÂ Â Â Â Â Â Â Â Â Â 250 mL Bottle<br>Code: 80456115Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â 100 mg/mLÂ Â Â Â Â Â Â Â Â Â 500 mL Bottle<br></p>
</div>
<div class="Section" data-sectionCode="34093-5">
<a name="i4i_references_id_5532ea85-3821-403e-87a7-a111fe6d5d07"></a><a name="section-16"></a><p></p>
<h1>REFERENCES:</h1>
<p class="First">1. Hooper, D. C., Wolfson, J. S., Quinolone Antimicrobial Agents,<span class="Italics"></span>2<span class="Sup">nd</span> ed, 59 - 75, 1993. </p>
<p>U.S. Patent No. 5,756,506<br>For customer service or to obtain product information, including a Safety Data Sheet, call 1-800-633-3796. <br>For medical emergencies or to report adverse reactions, call 1-800-422-9874.</p>
<div class="Figure">
<a name="id-275022683"></a><img alt="Bayer logo" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=401d2b8c-872b-4ffc-b100-22663b0f6bbb&amp;name=image-07.jpg">
</div>
<p>October 2014<br>80908653, R.5<br>Â©2014 Bayer HealthCare LLC</p>
<p><br>Baytril<span class="Sup">Â®</span>Â 100Â Â Â Â Â Â Â Â <br>Bayer, the Bayer Cross and Baytril are registered trademarks of Bayer.<br>NADA 141-068, Approved by FDA<br>Bayer HealthCare LLC, Animal Health Division<br>Shawnee Mission, Kansas 66201 U.S.A.<br>Made in Germany</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_3ce1874e-7c50-4128-aa84-5d09920f6ffa"></a><a name="section-17"></a><p></p>
<h1>Principal Display Panel â€“ 100 mL Carton Label</h1>
<div class="Figure">
<a name="id-686747838"></a><img alt="Baytril 100 (enrofloxacin) 100 mg/mL Antimicrobial Injectable Solution 100 mL label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=401d2b8c-872b-4ffc-b100-22663b0f6bbb&amp;name=image-06.jpg">
</div>
<p class="First">Baytril<span class="Sup">Â®</span> 100<br>(enrofloxocin)<br>100 mg/mL Antimicrobial<br>Injectable Solution</p>
<p>For Subcutaneous Use in Beef Cattle And<br>Non-Lactating Dairy Cattle</p>
<p>For Intramuscular Or Subcutaneous Use in Swine</p>
<p>Not For Use in Female Dairy Cattle<br>20 Months of Age or Older<br>Or in Calves To Be Processed For Veal</p>
<p>CAUTION: Federal (U.S.A.) law restricts this drug to<br>use by or on the order of a licensed veterinarian.</p>
<p>Federal (U.S.A.) law prohibits the extra-label use of<br>this drug in food-producing animals.</p>
<p>To assure responsible antimicrobial drug use, enrofloxacin<br>should only be used as a second-line drug for colibacillosis in<br>swine following consideration of other therapeutic options.</p>
<p>100 mL</p>
<p>Bayer HealthCare LLC, Animal Health Division<br>Shawnee Mission, Kansas 66201 U.S.A.<br>Made in Germany<br>NADA 141-068, Approved by FDA<br>Bayer, the Bayer Cross and Baytril are registered trademarks of Bayer.</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="ID_121a4d6f-93d5-461c-bd31-d365fefa799a"></a><a name="section-18"></a><p></p>
<h1>Principal Display Panel â€“ 100 mL Bottle Label</h1>
<div class="Figure">
<a name="id291650434"></a><img alt="Baytril 100 (enrofloxacin) 100 mg/mL Antimicrobial Injectable Solution 100 mL bottle label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=401d2b8c-872b-4ffc-b100-22663b0f6bbb&amp;name=image-02.jpg">
</div>
<p class="First">Baytril<span class="Sup">Â®</span> 100<br>(enrofloxocin)<br>100 mg/mL Antimicrobial Injectable Solution</p>
<p>For Subcutaneous Use in Beef Cattle And Non-Lactating Dairy Cattle</p>
<p>For Intramuscular Or Subcutaneous Use in Swine</p>
<p>Not For Use in Female Dairy Cattle 20 Months of Age or Older<br>Or in Calves To Be Processed For Veal</p>
<p>CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian.</p>
<p>Federal (U.S.A.) law prohibits the extra-label use of this drug in food-producing animals.</p>
<p>To assure responsible antimicrobial drug use, enrofloxacin should only be used as a second-line<br>drug for colibacillosis in swine following consideration of other therapeutic options.</p>
<p>100 mL</p>
<p>Bayer HealthCare LLC, Animal Health Division<br>Shawnee Mission, Kansas 66201 U.S.A. Made in Germany<br>NADA 141-068, Approved by FDA</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="ID_fe88d595-edf2-4fa5-b036-2dffd7fac9df"></a><a name="section-19"></a><p></p>
<h1>Principal Display Panel â€“ 250 mL Carton Label</h1>
<div class="Figure">
<a name="id283473412"></a><img alt="Baytril 100 (enrofloxacin) 100 mg/mL Antimicrobial Injectable Solution 250 mL label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=401d2b8c-872b-4ffc-b100-22663b0f6bbb&amp;name=image-03.jpg">
</div>
<p class="First">Baytril<span class="Sup">Â®</span> 100<br>(enrofloxocin)<br>100 mg/mL Antimicrobial<br>Injectable Solution</p>
<p>For Subcutaneous Use in Beef Cattle And<br>Non-Lactating Dairy Cattle</p>
<p>For Intramuscular Or Subcutaneous Use in Swine</p>
<p>Not For Use in Female Dairy Cattle<br>20 Months of Age or Older<br>Or in Calves To Be Processed For Veal</p>
<p>CAUTION: Federal (U.S.A.) law restricts this <br>drug to use by or on the order of a licensed veterinarian.</p>
<p>Federal (U.S.A.) law prohibits the extra-label <br>use of this drug in food-producing animals.</p>
<p>To assure responsible antimicrobial drug use, <br>enrofloxacin should only be used as a second-line <br>drug for colibacillosis in swine following <br>consideration of other therapeutic options.</p>
<p>250 mL</p>
<p>Bayer HealthCare LLC, Animal Health Division<br>Shawnee Mission, Kansas 66201 U.S.A.<br>Made in Germany<br>NADA 141-068, Approved by FDA</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="ID_c05b2b42-ef6e-44cb-8205-a424243a9fc3"></a><a name="section-20"></a><p></p>
<h1>Principal Display Panel â€“ 250 mL Bottle Label</h1>
<div class="Figure">
<a name="id179710082"></a><img alt="Baytril 100 (enrofloxacin) 250 mg/mL Antimicrobial Injectable Solution 100 mL bottle label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=401d2b8c-872b-4ffc-b100-22663b0f6bbb&amp;name=image-04.jpg">
</div>
<p class="First">Baytril<span class="Sup">Â®</span> 100<br>(enrofloxocin)<br>100 mg/mL Antimicrobial Injectable Solution</p>
<p>For Subcutaneous Use in Beef Cattle And Non-Lactating Dairy Cattle</p>
<p>For Intramuscular Or Subcutaneous Use in Swine</p>
<p>Not For Use in Female Dairy Cattle 20 Months of Age or Older<br>Or in Calves To Be Processed For Veal</p>
<p>CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian.<br>Federal (U.S.A.) law prohibits the extra-label use of this drug in food-producing animals.</p>
<p>To assure responsible antimicrobial drug use, enrofloxacin should only be used as a second-line<br>drug for colibacillosis in swine following consideration of other therapeutic options.</p>
<p>250 mL</p>
<p>Bayer HealthCare LLC, Animal Health Division<br>Shawnee Mission, Kansas 66201 U.S.A. Made in Germany<br>NADA 141-068, Approved by FDA</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="ID_5a304f18-333c-460c-8411-3d6d6aab8eab"></a><a name="section-21"></a><p></p>
<h1>Principal Display Panel â€“ 500 mL Bottle Label</h1>
<div class="Figure">
<a name="id574858096"></a><img alt="Baytril 100 (enrofloxacin) 100 mg/mL Antimicrobial Injectable Solution 500 mL bottle label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=401d2b8c-872b-4ffc-b100-22663b0f6bbb&amp;name=image-05.jpg">
</div>
<p class="First">Baytril<span class="Sup">Â®</span> 100<br>(enrofloxocin)<br>100 mg/mL Antimicrobial Injectable Solution</p>
<p>For Subcutaneous Use in Beef Cattle And <br>Non-Lactating Dairy Cattle</p>
<p>For Intramuscular Or Subcutaneous Use in Swine</p>
<p>Not For Use in Female Dairy Cattle 20 Months of <br>Age Or Older Or in Calves To Be Processed For Veal</p>
<p>CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian.<br>Federal (U.S.A.) law prohibits the extra-label use of this drug in food-producing animals.</p>
<p>To assure responsible antimicrobial drug use, enrofloxacin should only be used as a second-line<br>drug for colibacillosis in swine following consideration of other therapeutic options.</p>
<p>500 mL</p>
<p>Bayer HealthCare LLC, Animal Health Division<br>Shawnee Mission, Kansas 66201 U.S.A. Made in Germany<br>NADA 141-068, Approved by FDA</p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>BAYTRILÂ 		
					</strong><br><span class="contentTableReg">enrofloxacin injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">PRESCRIPTION ANIMAL DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0859-2231</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">SUBCUTANEOUS, INTRAMUSCULAR</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>ENROFLOXACIN</strong> (ENROFLOXACIN) </td>
<td class="formItem">ENROFLOXACIN</td>
<td class="formItem">100Â mg Â inÂ 1Â mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>BENZYL ALCOHOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0859-2231-01</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0859-2231-04</td>
<td class="formItem">100 mL in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:0859-2231-02</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:0859-2231-05</td>
<td class="formItem">250 mL in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">3</th>
<td class="formItem">NDC:0859-2231-03</td>
<td class="formItem">500 mL in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NADA</td>
<td class="formItem">NADA141068</td>
<td class="formItem">07/24/1998</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Bayer HealthCare LLC Animal Health Division
							(152266193)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 6/2015<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>efc47355-1b4e-411c-8994-0179b3797d00</div>
<div>Set id: 401d2b8c-872b-4ffc-b100-22663b0f6bbb</div>
<div>Version: 7</div>
<div>Effective Time: 20150616</div>
</div>
</div>Â <div class="DistributorName">Bayer HealthCare LLC Animal Health Division</div></p>
</body></html>
